Nacia Pupo Taylor

Nacia Pupo Taylor

Nácia Pupo Taylor leads initiatives focused on health systems sustainability, global health security, anti-microbial resistance, emerging infectious diseases, and vaccines.  Nácia is passionate about improving healthcare for everyone, everywhere and a strong believer...
Michael Lobritz

Michael Lobritz

Michael Lobritz is the Head of Infectious Diseases Early Development at F. Hoffmann-La Roche, Ltd, based in Basel, Switzerland. His group is responsible for the translational development of Roche antibiotics and antivirals from Phase 0 through Phase 2, including the...
Najy Alsayed

Najy Alsayed

Currently, Global Therapeutic Area Head for Infectious Diseases at Menarini Group. His over 25 years’ experience and expertise in Pharma covers various disease fields including CNS, Gastroenterology, Bone diseases, oncology and infectious disease including vaccines...
John Billington

John Billington

Head of Health Security and Infectious Disease Policy and Advocacy John Billington is Head of Health Security and Infectious Disease Policy and Advocacy in the global corporate government affairs department of GSK. In this role, he is responsible for the company’s...